GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (NAS:GHRS) » Definitions » Price-to-Funds-From-Operations

GHRS (GH Research) Price-to-Funds-From-Operations : (As of Apr. 15, 2025)


View and export this data going back to 2021. Start your Free Trial

What is GH Research Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


GH Research Business Description

Industry
Traded in Other Exchanges
Address
Dawson Street, Joshua Dawson House, Dublin 2, IRL, D02 RY95
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.